Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters
- PMID: 21852570
- DOI: 10.1148/radiol.11103515
Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters
Abstract
Purpose: To prospectively determine whether dynamic contrast material-enhanced (DCE) magnetic resonance (MR) quantitative parameters correlate with fibrosis and microvascular density (MVD) in malignant and benign solid pancreatic focal lesions and nontumoral pancreatic tissue.
Materials and methods: The institutional review board approved the study; written informed consent was obtained. DCE MR was performed in 28 patients with surgically resectable focal pancreatic lesions. DCE MR quantitative parameters derived from one-compartment (OC) (transfer rate constant [K(trans)] and distribution fraction [ƒ]) and two-compartment (TC) (K(trans), tissue volume fraction occupied by extravascular extracellular space [v(i)], and tissue volume fraction occupied by vascular space [v(p)]) pharmacokinetic models were correlated with fibrosis content and MVD counts in focal lesions and nontumoral tissue (Spearman correlation coefficient [SCC]). Pharmacokinetic parameters were compared (Mann-Whitney test) between tumoral and nontumoral tissue. Diagnostic performance of DCE MR fibrosis detection was assessed (receiver operator characteristic curve analysis).
Results: K(trans) OC and K(trans) TC were significantly lower in primary malignant tumors compared with benign lesions (P = .023) and nontumoral pancreatic tissue downstream (P < .001) and upstream (P = .006); ƒ and v(i) were significantly higher in primary malignant tumors compared with nontumoral pancreatic tissue downstream (P = .012 and .018, respectively). Fibrosis was correlated negatively with K(trans) OC (SCC, -0.600) and K(trans) TC (SCC, -0.564) and positively with ƒ (SCC, 0.514) and v(i) (SCC, 0.464), with P < .001 (all comparisons). MVD was positively correlated with ƒ (SCC, 0.355; P = .019) and v(i) (SCC, 0.297; P = .038) but not with K(trans) OC (SCC, -0.140; P = .33) and K(trans) TC (SCC, -0.194; P = .181). Sensitivity and specificity for fibrosis detection were 65% (24 of 37) and 83% (10 of 12) for K(trans) OC (cutoff value, 0.35 min(-1)) and 76% (28 of 37) and 83% (10 of 12) for K(trans) TC (cutoff value, 0.29 min(-1)), respectively.
Conclusion: Quantitative DCE MR parameters, derived from pharmacokinetic models in malignant and benign pancreatic solid lesions and nontumoral pancreatic tissue, were significantly correlated with fibrosis and MVD.
Supplemental material: http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.11103515/-/DC1.
RSNA, 2011
Similar articles
-
Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.Radiology. 2013 Jan;266(1):185-96. doi: 10.1148/radiol.12120111. Epub 2012 Nov 28. Radiology. 2013. PMID: 23192779
-
Apparent Diffusion Coefficient and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Pancreatic Cancer: Characteristics and Correlation With Histopathologic Parameters.J Comput Assist Tomogr. 2016 Sep-Oct;40(5):709-16. doi: 10.1097/RCT.0000000000000434. J Comput Assist Tomogr. 2016. PMID: 27224231
-
Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.Radiology. 2011 Nov;261(2):394-403. doi: 10.1148/radiol.11102413. Epub 2011 Aug 9. Radiology. 2011. PMID: 21828189 Free PMC article.
-
Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer.Magn Reson Imaging Clin N Am. 2018 Feb;26(1):135-149. doi: 10.1016/j.mric.2017.08.008. Epub 2017 Oct 21. Magn Reson Imaging Clin N Am. 2018. PMID: 29128001 Review.
-
Assessment of Tumor Angiogenesis: Dynamic Contrast-enhanced MR Imaging and Beyond.Magn Reson Imaging Clin N Am. 2016 Feb;24(1):45-56. doi: 10.1016/j.mric.2015.08.010. Epub 2015 Oct 27. Magn Reson Imaging Clin N Am. 2016. PMID: 26613875 Review.
Cited by
-
Incorporating prognostic imaging biomarkers into clinical practice.Cancer Imaging. 2013 Sep 23;13(3):332-41. doi: 10.1102/1470-7330.2013.9003. Cancer Imaging. 2013. PMID: 24060808 Free PMC article. Review.
-
Dynamic non-invasive ASL perfusion imaging of a normal pancreas with secretin augmented MR imaging.Eur Radiol. 2018 Jun;28(6):2389-2396. doi: 10.1007/s00330-017-5227-8. Epub 2018 Jan 4. Eur Radiol. 2018. PMID: 29302785
-
Six-dimensional quantitative DCE MR Multitasking of the entire abdomen: Method and application to pancreatic ductal adenocarcinoma.Magn Reson Med. 2020 Aug;84(2):928-948. doi: 10.1002/mrm.28167. Epub 2020 Jan 21. Magn Reson Med. 2020. PMID: 31961967 Free PMC article.
-
Extracellular volume fraction determined by equilibrium contrast-enhanced multidetector computed tomography as a prognostic factor in unresectable pancreatic adenocarcinoma treated with chemotherapy.Eur Radiol. 2019 Jan;29(1):353-361. doi: 10.1007/s00330-018-5570-4. Epub 2018 Jun 19. Eur Radiol. 2019. PMID: 29922930
-
Rim enhancement of pancreatic ductal adenocarcinoma: investigating the relationship with DCE-MRI-based radiomics and next-generation sequencing.Front Oncol. 2024 Mar 8;14:1304187. doi: 10.3389/fonc.2024.1304187. eCollection 2024. Front Oncol. 2024. PMID: 38525415 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous